Philip A Chan1, Tiffany R Glynn, Catherine E Oldenburg, Madeline C Montgomery, Ashley E Robinette, Alexi Almonte, Julia Raifman, Leandro Mena, Rupa Patel, Kenneth H Mayer, Laura S Beauchamps, Amy S Nunn. 1. From the *Division of Infectious Diseases, The Miriam Hospital, †Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI; ‡Department of Epidemiology, Harvard School of Public Health, Boston, MA; §Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ¶Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS; ∥Division of Infectious Diseases, Washington University, St. Louis, MO; and **The Fenway Institute, Fenway Health, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Abstract
BACKGROUND: Preexposure prophylaxis (PrEP) is efficacious in preventing human immunodeficiency virus (HIV) among men who have sex with men (MSM). We assessed PrEP uptake among MSM presenting for services at a sexually transmitted diseases (STD) clinic. METHODS: Men who have sex with men presenting to the Rhode Island STD Clinic between October 2013 and November 2014 were educated about, and offered, PrEP. We categorized PrEP engagement using an implementation cascade to describe gaps in uptake which described MSM who: (1) were educated about PrEP, (2) indicated interest, (3) successfully received follow-up contact, (4) scheduled an appointment, (5) attended an appointment, and (6) initiated PrEP (ie, received a prescription). Bivariate and multivariable logistic regression models were used to examine predictors of PrEP initiation. RESULTS: A total of 234 MSM were educated about PrEP; of these, 56% expressed interest. Common reasons for lack of interest were low HIV risk perception (37%), wanting more time to consider (10%), concern about side effects (7%), and financial barriers (3%). Among those interested, 53% followed up. Of those, 51% scheduled an appointment. The most common reason patients did not schedule an appointment was low HIV risk perception (38%). Seventy-seven percent of those with an appointment attended the appointment; of those, 93% initiated PrEP. Patients with higher HIV-risk perception (adjusted odds ratios, 2.17; 95% confidence interval, 1.29-3.64) and a history of sex with an HIV-positive partner (adjusted odds ratios, 7.08; 95% confidence interval, 2.35-21.34) had significantly higher odds of initiating PrEP. CONCLUSIONS: Low HIV-risk perception was the most significant barrier to PrEP uptake among MSM attending a public STD clinic.
BACKGROUND: Preexposure prophylaxis (PrEP) is efficacious in preventing human immunodeficiency virus (HIV) among men who have sex with men (MSM). We assessed PrEP uptake among MSM presenting for services at a sexually transmitted diseases (STD) clinic. METHODS:Men who have sex with men presenting to the Rhode Island STD Clinic between October 2013 and November 2014 were educated about, and offered, PrEP. We categorized PrEP engagement using an implementation cascade to describe gaps in uptake which described MSM who: (1) were educated about PrEP, (2) indicated interest, (3) successfully received follow-up contact, (4) scheduled an appointment, (5) attended an appointment, and (6) initiated PrEP (ie, received a prescription). Bivariate and multivariable logistic regression models were used to examine predictors of PrEP initiation. RESULTS: A total of 234 MSM were educated about PrEP; of these, 56% expressed interest. Common reasons for lack of interest were low HIV risk perception (37%), wanting more time to consider (10%), concern about side effects (7%), and financial barriers (3%). Among those interested, 53% followed up. Of those, 51% scheduled an appointment. The most common reason patients did not schedule an appointment was low HIV risk perception (38%). Seventy-seven percent of those with an appointment attended the appointment; of those, 93% initiated PrEP. Patients with higher HIV-risk perception (adjusted odds ratios, 2.17; 95% confidence interval, 1.29-3.64) and a history of sex with an HIV-positive partner (adjusted odds ratios, 7.08; 95% confidence interval, 2.35-21.34) had significantly higher odds of initiating PrEP. CONCLUSIONS: Low HIV-risk perception was the most significant barrier to PrEP uptake among MSM attending a public STD clinic.
Authors: Duncan A MacKellar; Linda A Valleroy; Gina M Secura; Stephanie Behel; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene LaLota; Douglas Shehan; Hanne Thiede; Lucia V Torian Journal: AIDS Behav Date: 2007-03
Authors: Scott E Kellerman; J Stan Lehman; Amy Lansky; Mark R Stevens; Frederick M Hecht; Andrew B Bindman; Pascale M Wortley Journal: J Acquir Immune Defic Syndr Date: 2002-10-01 Impact factor: 3.731
Authors: Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill Journal: Lancet Date: 2015-09-09 Impact factor: 79.321
Authors: Lauren B Beach; George J Greene; Peter Lindeman; Amy K Johnson; Christian N Adames; Matthew Thomann; Patrick C T Washington; Gregory Phillips Journal: AIDS Patient Care STDS Date: 2018-11 Impact factor: 5.078
Authors: Meredith E Clement; Barbara E Johnston; Cedar Eagle; Destry Taylor; Anna Lina Rosengren; Benjamin A Goldstein; Arlene C Seña Journal: AIDS Patient Care STDS Date: 2019-06-24 Impact factor: 5.078
Authors: Kenneth H Mayer; Philip A Chan; Rupa R Patel; Charlene A Flash; Douglas S Krakower Journal: J Acquir Immune Defic Syndr Date: 2018-02-01 Impact factor: 3.731
Authors: Catherine E Oldenburg; Amy S Nunn; Madeline Montgomery; Alexi Almonte; Leandro Mena; Rupa R Patel; Kenneth H Mayer; Philip A Chan Journal: AIDS Behav Date: 2018-04
Authors: Laio Magno; Inês Dourado; Cassandra Sutten Coats; Daniel Wilhite; Luís Augusto V da Silva; Oluwadamilola Oni-Orisan; Julianna Brown; Fabiane Soares; Lígia Kerr; Yusuf Ransome; Philip Andrew Chan; Amy Nunn Journal: Glob Public Health Date: 2019-02-04
Authors: Christina J Sun; Kirsten M Anderson; David Bangsberg; Kim Toevs; Dayna Morrison; Caitlin Wells; Pete Clark; Christina Nicolaidis Journal: J Gen Intern Med Date: 2019-02-04 Impact factor: 5.128
Authors: Marisa Felsher; Eliza Ziegler; Laramie R Smith; Susan G Sherman; K Rivet Amico; Rachel Fox; Kayla Madden; Alexis M Roth Journal: Arch Sex Behav Date: 2020-04-09
Authors: Onyema Ogbuagu; Brandon D L Marshall; Perry Tiberio; Adedotun Ogunbajo; Lydia Barakat; Madeline Montgomery; Alexi Almonte; Tyler Wray; Emily C Williams; E Jennifer Edelman; Philip A Chan Journal: AIDS Behav Date: 2019-01